These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23819697)

  • 1. Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation.
    Duong HV; Westfield KC; Singleton IC
    Acta Ophthalmol; 2015 Jun; 93(4):e314-5. PubMed ID: 23819697
    [No Abstract]   [Full Text] [Related]  

  • 2. Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery.
    Lane SS; Holland EJ
    J Cataract Refract Surg; 2013 Feb; 39(2):168-73. PubMed ID: 23232255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after cataract surgery in patients with diabetes.
    Endo N; Kato S; Haruyama K; Shoji M; Kitano S
    Acta Ophthalmol; 2010 Dec; 88(8):896-900. PubMed ID: 19725815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of cystoid macular edema following routine cataract surgery using NSAIDs alone or with corticosteroids.
    Walter KA; Lee RY; Chen K; Komanski C
    Arq Bras Oftalmol; 2020; 83(1):55-61. PubMed ID: 31664337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine Use of Nonsteroidal Anti-inflammatory Drugs with Corticosteroids in Cataract Surgery: Beneficial or Redundant?
    Kim SJ; Patel SN; Sternberg P
    Ophthalmology; 2016 Mar; 123(3):444-6. PubMed ID: 26902558
    [No Abstract]   [Full Text] [Related]  

  • 6. Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery.
    Zaczek A; Artzen D; Laurell CG; Stenevi U; Montan P
    J Cataract Refract Surg; 2014 Sep; 40(9):1498-505. PubMed ID: 25135542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The anti-inflammatory effect of 0.1% bromfenac and 0.1% betamethasone combination in post-cataract surgery patients with diabetes mellitus].
    Terada Y; Masuda A; Nejima R; Maruyama Y; Miyata K
    Nippon Ganka Gakkai Zasshi; 2014 Aug; 118(8):645-51. PubMed ID: 25223209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenac.
    Wolf EJ; Braunstein A; Shih C; Braunstein RE
    J Cataract Refract Surg; 2007 Sep; 33(9):1546-9. PubMed ID: 17720068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification.
    Wang QW; Yao K; Xu W; Chen PQ; Shentu XC; Xie X; Weng Y; Zhang L; Jin CF; Wu W; Zhu YN; Yu YH
    Ophthalmologica; 2013; 229(4):187-94. PubMed ID: 23429038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are topical NSAIDs needed for routine cataract surgery?
    Kim A; Stark WJ
    Am J Ophthalmol; 2008 Oct; 146(4):483-5. PubMed ID: 18804560
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of postoperative administration of nonsteroidal antiinflammatory drugs and steroids on the conformational changes in wound healing after cataract surgery.
    Choi EY; Kang HG; Kim TI; Kim EK; Lee HK
    J Cataract Refract Surg; 2016 Dec; 42(12):1804-1813. PubMed ID: 28007113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracameral triamcinolone acetonide after pediatric cataract surgery.
    Cleary CA; Lanigan B; O'Keeffe M
    J Cataract Refract Surg; 2010 Oct; 36(10):1676-81. PubMed ID: 20870112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate of pseudophakic cystoid macular edema using intraoperative and topical nonsteroidal antiinflammatory drugs alone without steroids.
    Walter K; Kauffman L; Hess J
    J Cataract Refract Surg; 2020 Mar; 46(3):350-354. PubMed ID: 32142038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progresses in antiinflamatory treatment in cataract surgery].
    Stefan C; Pop A; Cojocaru I
    Oftalmologia; 2011; 55(3):89-93. PubMed ID: 22428297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care.
    O'Brien TP
    Curr Med Res Opin; 2005 Jul; 21(7):1131-7. PubMed ID: 16004683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of macular oedema in diabetic patients undergoing cataract surgery.
    Boscia F; Giancipoli E; D'Amico Ricci G; Pinna A
    Curr Opin Ophthalmol; 2017 Jan; 28(1):23-28. PubMed ID: 27661663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of intraocular inflammation associated with cataract surgery.
    McColgin AZ; Heier JS
    Curr Opin Ophthalmol; 2000 Feb; 11(1):3-6. PubMed ID: 10724825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery.
    Miyanaga M; Miyai T; Nejima R; Maruyama Y; Miyata K; Kato S
    Acta Ophthalmol; 2009 May; 87(3):300-5. PubMed ID: 19183412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery.
    Miyake K; Ota I; Miyake G; Numaga J
    J Cataract Refract Surg; 2011 Sep; 37(9):1581-8. PubMed ID: 21855758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ophthalmic utility of topical bromfenac, a twice-daily nonsteroidal anti-inflammatory agent.
    Jones J; Francis P
    Expert Opin Pharmacother; 2009 Oct; 10(14):2379-85. PubMed ID: 19735215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.